Literature DB >> 35657406

Movement disorders and neuropathies: overlaps and mimics in clinical practice.

Francesco Gentile1,2, Alessandro Bertini1,2, Alberto Priori1,2, Tommaso Bocci3,4.   

Abstract

Movement disorders as well as peripheral neuropathies are extremely frequent in the general population; therefore, it is not uncommon to encounter patients with both these conditions. Often, the coexistence is coincidental, due to the high incidence of common causes of peripheral neuropathy, such as diabetes and other age-related disorders, as well as of Parkinson disease (PD), which has a typical late onset. Nonetheless, there is broad evidence that PD patients may commonly develop a sensory and/or autonomic polyneuropathy, triggered by intrinsic and/or extrinsic mechanisms. Similarly, some peripheral neuropathies may develop some movement disorders in the long run, such as tremor, and rarely dystonia and myoclonus, suggesting that central mechanisms may ensue in the pathogenesis of these diseases. Although rare, several acquired or hereditary causes may be responsible for the combination of movement and peripheral nerve disorders as a unique entity, some of which are potentially treatable, including paraneoplastic, autoimmune and nutritional aetiologies. Finally, genetic causes should be pursued in case of positive family history, young onset or multisystemic involvement, and examined for neuroacanthocytosis, spinocerebellar ataxias, mitochondrial disorders and less common causes of adult-onset cerebellar ataxias and spastic paraparesis. Deep phenotyping in terms of neurological and general examination, as well as laboratory tests, neuroimaging, neurophysiology, and next-generation genetic analysis, may guide the clinician toward the correct diagnosis and management.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Genetics; Inflammatory; Movement disorders; Paraneoplastic; Parkinsonisms; Peripheral neuropathy; a-Synuclein

Mesh:

Year:  2022        PMID: 35657406     DOI: 10.1007/s00415-022-11200-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  132 in total

1.  Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.

Authors:  Cory Toth; Kim Breithaupt; Shaohua Ge; Yanjun Duan; Joan M Terris; Anita Thiessen; Samuel Wiebe; Douglas W Zochodne; Oksana Suchowersky
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

Review 2.  Peripheral neuropathy in Parkinson's disease.

Authors:  Dion A Paul; Abdul Rehman M Qureshi; Abdul Qayyum Rana
Journal:  Neurol Sci       Date:  2020-05-01       Impact factor: 3.307

3.  Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.

Authors:  Roberto Ceravolo; Giovanni Cossu; Monica Bandettini di Poggio; Lucio Santoro; Paolo Barone; Maurizio Zibetti; Daniela Frosini; Valentina Nicoletti; Fiore Manganelli; Rosa Iodice; Marina Picillo; Aristide Merola; Leonardo Lopiano; Alessandra Paribello; Davide Manca; Maurizio Melis; Roberta Marchese; Paolo Borelli; Alessandra Mereu; Paolo Contu; Giovanni Abbruzzese; Ubaldo Bonuccelli
Journal:  Mov Disord       Date:  2013-07-08       Impact factor: 10.338

4.  Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.

Authors:  Imke Galazky; Julia Schoof; Sabine Stallforth; Andreas Kupsch; Hans-Jochen Heinze; Christian Kluge
Journal:  Parkinsonism Relat Disord       Date:  2013-08-22       Impact factor: 4.891

5.  Peripheral neuropathy is associated with more frequent falls in Parkinson's disease.

Authors:  Mélanie L Beaulieu; Martijn L T M Müller; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2018-04-03       Impact factor: 4.891

6.  Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Authors:  Davide Manca; Giovanni Cossu; Daniela Murgia; Andrea Molari; Paola Ferrigno; Emanuele Marcia; Maurizio Melis
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

7.  Neuropathy in Parkinson disease: prevalence and determinants.

Authors:  Yusuf A Rajabally; Jean Martey
Journal:  Neurology       Date:  2011-11-02       Impact factor: 9.910

Review 8.  The wrong end of the telescope: neuromuscular mimics of movement disorders (and vice versa).

Authors:  B R Bloem; N C Voermans; M B Aerts; K P Bhatia; B G M van Engelen; B P van de Warrenburg
Journal:  Pract Neurol       Date:  2016-03-10

Review 9.  Peripheral neuropathy in idiopathic Parkinson's disease: A systematic review.

Authors:  Panagiotis Zis; Richard A Grünewald; Ray Kallol Chaudhuri; Marios Hadjivassiliou
Journal:  J Neurol Sci       Date:  2017-05-11       Impact factor: 3.181

10.  Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.

Authors:  Paolo Lamberti; Stefano Zoccolella; Giovanni Iliceto; Elio Armenise; Angela Fraddosio; Michele de Mari; Paolo Livrea
Journal:  Mov Disord       Date:  2005-01       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.